The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy

American Journal of Perinatology

Volumn 25, Issue 4, 2008, Pages 233-237

  Mastrobattista, Joan M ^a   Klebanoff, Mark A ^b   Carey, J Christopher ^c   Hauth, John C ^d   MacPherson, Cora A ^e   Ernest, J ^f   Cotroneo, Margaret ^g   Leveno, Kenneth J ^h   Wapner, Ronald ⁱ   Varner, Michael ^j   Iams, Jay D ^k   Moawad, Atef ^l   Sibai, Baha M ^m   Miodovnik, Menachem ⁿ   Dombrowski, Mitchell ^o   O'Sullivan, Mary J ^p   VanDorsten, J Peter ^q   Langer, Oded ^r  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ New York Presbyterian Columbia University Medical Center   (United States)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^m UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁿ WASHINGTON HOSPITAL CENTER   (United States)

^o ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^p UNIVERSITY OF MIAMI   (United States)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^r ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

more..

Author keywords

Bacterial vaginosis; Body mass index; Pregnancy; Treatment

Indexed keywords

METRONIDAZOLE; PLACEBO; ANTIPROTOZOAL AGENT;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; MARRIAGE; MATERNAL AGE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SINGLE DRUG DOSE; SMOKING; TREATMENT FAILURE; TRICHOMONAS VAGINALIS; VAGINITIS; MORBID OBESITY; PREGNANCY; PREGNANCY COMPLICATION; TREATMENT OUTCOME;

ADULT; ANTIPROTOZOAL AGENTS; BODY MASS INDEX; FEMALE; HUMANS; METRONIDAZOLE; OBESITY, MORBID; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRICHOMONAS VAGINITIS;

EID: 46349111107     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-2008-1066875     Document Type: Article

References (15)

1. National CDC. Center for Chronic Disease Prevention and Health Promotion: Nutrition and Physical Activity. Defining overweight and obesity. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/defining.htm
2. Cheymol G. Drug pharmacokinetics in the obese. Fundam Clin Pharmacol 1988;2(3):239-256
3. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-540
4. Koumans EH, Markowitz LE, Hogan V, for the CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 2002;35(Suppl 2):S152-S172
5. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-1736
6. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-1742
7. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslei P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139-147
8. Carey JC, Klebanoff MA, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What have we learned about vaginal infections and preterm birth? Semin Perinatol 2003;27:212-216
9. Kekki M, Kurki T, Kotomaki T, Sintonen H, Paavonen J. Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth. Acta Obstet Gynecol Scand 2004;83:27-36
10. Tebes CC, Lynch C, Sinnott J. The effect of treating bacterial vaginosis on preterm labor. Infect Dis Obstet Gynecol 2003;11:123-129
11. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301
12. Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985;7:287-313
13. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003;20:405-414
14. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infections. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York: McGraw-Hill Medical Publishing Division; 2001:1097-1120
15. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006;55(No. RR-11):1-94